Health Condition 1: A00-B99- Certain infectious and parasitic diseases
Conditions
Interventions
Intervention1: NIL. This study is a single center retrospective, non interventional study.: NIL. This study is a single center retrospective, non interventional study.
Sponsors
Medanta Institute of Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients, Bacteremic patients with Documented MDR GNB infection, Received ceftazidimeavibactam for atleast 48 hours as per clinician’s discretion
Exclusion criteria
Exclusion criteria: Documented Acinetobacter infection, Pure MBL isolated (if available)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Clinical outcomes at Day 3 & day 14/EOT from the initiation of ceftazidime avibactam 2) Mortality at day 14Timepoint: Day 3 & Day 14/ End of Treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) All cause mortality at day 30 2) Day of ceftazidime avibactam initiation, average dose and duration 3) No of patients-initiated with Ceftazidime avibactam within 48-72 hour after diagnosis and outcomes correlation 4) Source of bacteremia 5) Causative organism, median time from admission to isolation of organism from culture 6) Molecular typing outcomes if available, susceptibility for ceftazidime-avibactam 7) Concomitant medications (baseline & combination) 8) Length of hospital stayTimepoint: Day 30 | — |
Countries
India
Contacts
Public ContactDr Deepak Govil
Medanta The Medicity, Gurgaon
Outcome results
None listed